BioNTech SE (BNTX) Interest Expenses (2018 - 2025)
BioNTech SE (BNTX) posted Interest Expenses of -$4.9 million for Q4 2025, up 83.4% on a QoQ basis from -$29.5 million in Q3 2025, and up 63.69% year-over-year from -$3.0 million in Q4 2024.
BioNTech SE (BNTX) has 8 years of Interest Expenses data on file, last reported at -$4.9 million in Q4 2025.
- In Q4 2025, Interest Expenses rose 63.69% year-over-year to -$4.9 million; the TTM figure through Dec 2025 stood at -$77.9 million (down 121.29% YoY), while the FY2025 annual figure was -$78.9 million, down 169.34% from the prior year.
- Interest Expenses grew to -$4.9 million in Q4 2025, from -$29.5 million in the prior quarter.
- Across five years, Interest Expenses topped out at $53.92 in Q1 2021 and bottomed at -$211.8 million in Q2 2021.
- A 5-year average of -$33.4 million and a median of -$7.9 million in 2024 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 100.05% in 2021, down 14815505.28% in 2021.
- Year by year, Interest Expenses stood at -$2.4 million in 2021, then slumped by 6656.8% to -$162.3 million in 2022, then jumped by 83.3% to -$27.1 million in 2023, then surged by 50.34% to -$13.5 million in 2024, then soared by 63.69% to -$4.9 million in 2025.
- The last three Interest Expenses figures came in at -$4.9 million (Q4 2025), -$29.5 million (Q3 2025), and -$7.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -4.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.89 Mn |
| Dec 31, 2025 | -4.89 Mn |
| Sep 30, 2025 | -29.46 Mn |
| Sep 30, 2025 | -29.46 Mn |
| Jun 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -7.92 Mn |
| Mar 31, 2025 | -35.66 Mn |
| Mar 31, 2025 | -35.66 Mn |
| Dec 31, 2024 | -13.46 Mn |
| Dec 31, 2024 | -13.46 Mn |
| Sep 30, 2024 | -8.79 Mn |
| Sep 30, 2024 | -8.79 Mn |
| Jun 30, 2024 | -7.86 Mn |
| Jun 30, 2024 | -7.86 Mn |
| Mar 31, 2024 | -5.11 Mn |
| Mar 31, 2024 | -5.11 Mn |
| Dec 31, 2023 | -27.11 Mn |
| Dec 31, 2023 | -27.11 Mn |
| Sep 30, 2023 | -2.18 Mn |
| Sep 30, 2023 | -2.18 Mn |
| Jun 30, 2023 | -1.42 Mn |
| Jun 30, 2023 | -1.42 Mn |
| Mar 31, 2023 | -31.13 Mn |
| Mar 31, 2023 | -31.13 Mn |
| Dec 31, 2022 | -162.32 Mn |
| Dec 31, 2022 | -162.32 Mn |
| Sep 30, 2022 | -4.34 Mn |
| Sep 30, 2022 | -4.34 Mn |
| Jun 30, 2022 | -6.19 Mn |
| Jun 30, 2022 | -6.19 Mn |
| Mar 31, 2022 | -7.52 Mn |
| Mar 31, 2022 | -7.52 Mn |
| Dec 31, 2021 | -2.40 Mn |
| Dec 31, 2021 | -2.40 Mn |
| Sep 30, 2021 | -97.53 Mn |
| Sep 30, 2021 | -97.53 Mn |
| Jun 30, 2021 | -211.83 Mn |
| Jun 30, 2021 | -211.83 Mn |
| Mar 31, 2021 | 53.92 |
| Mar 31, 2021 | 53.92 |
| Dec 31, 2020 | 16.22 |
| Dec 31, 2020 | 16.22 |
| Mar 31, 2020 | 110,393.90 |
| Mar 31, 2020 | 110,393.90 |
| Dec 31, 2019 | 2.47 Mn |
| Dec 31, 2019 | 2.47 Mn |
| Sep 30, 2019 | -91,243.86 |
| Sep 30, 2019 | -91,243.86 |
| Dec 31, 2018 | 13,641.97 |
| Dec 31, 2018 | 13,641.97 |
| Sep 30, 2018 | -1.38 Mn |
| Sep 30, 2018 | -1.38 Mn |